Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Postherpetic Neuralgia
Interventions
DRUG

Z160

DRUG

Placebo

Trial Locations (53)

10016

Investigative Site, New York

11235

Investigative Site, Brooklyn

20171

Investigative Site, Herndon

21045

Investigative Site, Columbia

27410

Investigative Site, Greensboro

29407

Investigative Site, Charleston

32127

Investigative Site, Port Orange

32806

Investigative Site, Orlando

33015

Investigative Site, Miami

33411

Investigative Site, Royal Palm Beach

33606

Investigative Site, Tampa

33756

Investigative Site, Clearwater

34243

Investigative Site, Sarasota

34601

Investigative Site, Brooksville

35216

Investigative Site, Birmingham

37205

Investigative Site, Nashville

37388

Investigative Site, Tullahoma

39564

Investigative Site, Ocean Springs

43214

Investigative Site, Columbus

45429

Investigative Site, Kettering

45432

Investigative Site, Beavercreek

47714

Investigative Site, Evansville

48104

Investigative Site, Ann Arbor

48706

Investigative Site, Bay City

60602

Investigative Site, Chicago

63031

Investigative Site, Hazelwood

63117

Investigative Site, St Louis

64114

Investigative Site, Kansas City

68124

Investigative Site, Omaha

71105

Investigative Site, Shreveport

72205

Investigative Site, Little Rock

73112

Investigative Site, Oklahoma City

75080

Investigative Site, Richardson

78731

Investigative Site, Austin

80218

Investigative Site, Denver

80304

Investigative Site, Boulder

80920

Investigative Site, Colorado Springs

84106

Investigative Site, Salt Lake City

84123

Investigative Site, Murray

85020

Investigative Site, Phoenix

85213

Investigative Site, Mesa

85224

Investigative Site, Chandler

85251

Investigative Site, Scottsdale

85381

Investigative Site, Peoria

87102

Investigative Site, Albuquerque

90033

Investigative Site, Los Angeles

91360

Investigative Site, Thousand Oaks

92618

Investigative Site, Irvine

94109

Investigative Site, San Francisco

98007

Investigative Site, Bellevue

98405

Investigative Site, Tacoma

02131

Investigative Site, Boston

08755

Investigative Site, Toms River

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zalicus

INDUSTRY

NCT01757873 - Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia | Biotech Hunter | Biotech Hunter